United States · FDA National Drug Code directory
Darifenacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72162-2570_2a6e97d9-19e4-42aa-86e8-27bab91f059d
- Product NDC
- 72162-2570
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Darifenacin
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161118
- Source listing expiry
- 20261231
Source-listed ingredients
- DARIFENACIN HYDROBROMIDE — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2570-3) · 72162-2570-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →